ZSFab, founded in 2017 in the United States, is dedicated to producing high performance, low-cost, customized medical implants, surgical guides, and anatomical models. The company's unique solutions integrate proprietary software tools, advanced modeling and optimization methods, and 3D printing technology. ZSFab aims to address the unique requirements of individuals by providing tailored replacements for worn, damaged, or aged body parts through additive manufacturing. The recent milestone for ZSFab was the Seed Round investment at 22 September 2021, with participation from notable investors including Ferry Venture Capital, Celtic House Asia Partners, Taihill Venture, iVision Ventures, and Qingyuan Chuangtou. The company's focus on Health Care, Medical Devices, and 3D Printing aligns with current industry trends, presenting an attractive opportunity for venture capital consideration. ZSFab's mission to provide innovative solutions for the healthcare sector, including surgical processes, positions it as a potential disruptor in the medical technology space. Their "Made To Fit" approach emphasizes the importance of individualized healthcare and the use of cutting-edge technology to improve patient outcomes. Overall, ZSFab's unique value proposition, combined with its recent investment milestone, establishes it as an intriguing prospect for venture capital firms seeking opportunities in the healthcare and 3D printing sectors.
No recent news or press coverage available for ZSFab.